← Open Payments lookup

MARY DORE: Open Payments

NPI 1689438764 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$559 in 28 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $559

Food & beverage: $559
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$163
Vanda Pharmaceuticals Inc.3$73
Sumitomo Pharma America, Inc.3$72
Axsome Therapeutics, Inc.3$57
ABBVIE INC.2$49
Evofem Biosciences, Inc.3$29
TOLMAR, INC.1$21
Lundbeck LLC1$19
Otsuka Pharmaceutical Development & Commercialization, Inc.1$18
Lilly USA, LLC1$15

Products named: CAPLYTA, FANAPT, GEMTESA, Auvelity, VRAYLAR, Phexxi, JATENZO, REXULTI.

Industry payments across LA — which companies pay providers there.